To confirm that Hpo pathway regulates NF-κB signaling in ccRCC, we carried out qPCR experiments to measure the change in NF-κB target gene expression in ccRCC upon treatment with XMU-MP-1 at different doses or at a fixed concentration for increasing amount of time. The gene discussed is NFKB1; the disease is nonpapillary renal cell carcinoma.